These effects were similar in magnitude to risk reductions observed with tamoxifen in early studies, although this comparison reflects effect size rather than equivalent evidence strength or clinical readiness
The boxes represent the quartiles of the data while the whiskers represent 1.5 times the interquartile range
While it is still unclear as to what may cause a person taking a GLP-1 medication to experience an eye issue, researchers hypothesize that rapid changes in blood sugar levels might contribute to these eye complications
A study published in Diabetes, Obesity and Metabolism (Frias et al., 2021) from an early phase 2 comparison found that tirzepatide produced dose-dependent weight loss that exceeded semaglutide 1 mg across all dose levels tested, confirming the advantage of the dual mechanism
Somatostatin normally puts the brakes on growth hormone release
Wholesale pricing with fast US shipping over $100 | New customers receive 5% off first purchase | Rx-only product for licensed healthcare professionals